GlassScriptPhysician profile
Jayraj C Shah
NPI 1457364671
$358.94
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
See the full distribution for Adolescent Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.40 · 2020: $35.34 · 2021: $193 · 2022: $40.79.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $100.01 | 2021 | |
| Esperion Therapeutics, INC. | $79.83 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $77.33 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $45.40 | 2019-2020 | |
| Abbvie INC. | $25.79 | 2022 | |
| Astellas Pharma US INC | $16.79 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.79 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayraj Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.